Stay Connected.
Get the inside scoop on company and product news. Subscribe to PBInsider, our quarterly e-newsletter, today!
Advancing Hemophilia A Testing with a Bovine Chromogenic FVIII Assay
October 22, 2025
Listen as Precision BioLogic’s Chief Scientific Officer F. Jon Geske, PhD and Marketing Director Ian Burns discuss advances in hemophilia A testing and treatment. Joining them are:
– Tara Quinton, R&D Scientist and part of Precision BioLogic’s Chromogenic FVIII assay design team, discussing the assay’s expanded utility along with new data that secured the assay’s FDA clearance
– Julie Tange, Principal Developer, Hematopathology at the Special Coagulation Laboratory, Mayo Clinic, relating her experiences with Precision BioLogic’s bovine assay